Clinical trial · Interventional
Early Palliative Care for Patients With Haematological Malignancies
Early Palliative Care for Patients With Haematological Malignancies: A Randomised Prospective Study
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Patients suffering from haematological disease present symptoms of discomfort and currently benefit from palliative care skills only for the management of their end-of-life. However, in medical oncology, more and more studies tend to demonstrate the benefit on the quality of life of an early collaboration between the two specialties. Investigator did the hypothesis that early integration of palliative care with conventional haematological care could decrease discomfort symptoms and add a real benefit on the patients' quality of life .
Conditions
Conditions (4)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Acute Myeloid Leukemia | Acute Myeloid Leukemia | CURATED_BROADER | 0.80 |
| Diffuse Large B Cell Lymphoma | Diffuse Large B-Cell Lymphoma | CURATED_BROADER | 0.80 |
| Myelodysplastic Syndrome | Myelodysplastic Syndrome | CURATED_BROADER | 0.80 |
| Palliative Care | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Early palliative care integration | Drug | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Conventional haematological care
- description
- Patients with haematological malignancy Conventional haematological care
- interventionNames
- Drug: Early palliative care integration
- type
- EXPERIMENTAL
- label
- Conventional care associated with a monthly consultation
- description
- Patients with haematological malignancy Conventional care associated with a monthly consultation realized by a palliative and supportive care team
- interventionNames
- Drug: Early palliative care integration
Primary outcomes (1)
- measure
- Quality of life evaluation: standardized questionnaire
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 70 Years
Show eligibility criteria text
Inclusion Criteria: * Patients are over 70 years old * Patients from being diagnosed with acute myeloid leukemia and high-risk myelodysplastic syndrome or after the third line of therapy for high-grade lymphoma. Exclusion Criteria: * All patients with a curative project (induction chemotherapy ou allogenic transplantation) * All patients in a terminal palliative status * Patients who don't speak French, * Patients not able to read and write * Patients who don't agree to participate in the protocol * Patients with psychiatric troubles or cognitive disorders * Patients under guardianship or curatorship, deprived of freedom or under justice protection.
References
Publications (0)
Data not yet available